Optimi Health Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPTH research report →
Price Chart
About the company
Based in Princeton, Canada, Optimi Health Corp. , established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners.
- CEO
- Dane Stevens
- IPO
- 2026
- Employees
- 6
- HQ
- Princeton, BC, CA
Get TickerSpark's AI analysis on OPTH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $15.84M
- P/E
- -4.02
- PEG
- 0.19
- P/S
- 93.61
- P/B
- 6.13
- EV/EBITDA
- -7.84
- Div Yield
- 0.00%
- Gross Margin
- -1323.71%
- Op Margin
- -2164.58%
- Net Margin
- -2330.08%
- ROE
- -94.46%
- ROIC
- -49.51%
Latest fiscal year · YoY change
- Revenue
- $426.90K+9.5%
- Gross Profit
- $-2,076,619-866.5%
- Op Income
- $-4,534,975
- Net Income
- $-3,717,287.4+38.4%
- EPS
- $-1.16+42.4%
- OCF Growth
- +38.6%
- FCF Growth
- +38.7%
- 52W High
- $6.40
- 52W Low
- $4.00
- 50D MA
- $4.88
- 200D MA
- $4.88
- Beta
- 1.59
- RSI (14)
- 52
- Avg Volume
- 191.56K
No earnings-call transcripts are available for OPTH yet.
- Free Float
- 74.2%
- Shares Outstanding
- 3.22M
- Float Shares
- 2.39M
Held by 1 ETFs
Biggest fund positions in OPTH by dollar value.
Our OPTH coverage
Recent articles, reports, and earnings notes.
Want a deeper read on OPTH?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
prnewswire.com · Jun 29
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
globenewswire.com · Jun 29
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
globenewswire.com · Jun 16
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
prnewswire.com · Jun 10
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
globenewswire.com · Jun 10
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
gurufocus.com · Jun 8
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
prnewswire.com · Jun 8
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
globenewswire.com · Jun 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
Bullish or bearish?
Where do you stand on OPTH?